Cinical trial investigators for aducanumab (Aduhelm) discuss the significance of the drug’s recent FDA approval, the controversy surrounding its efficacy, and the uncertainty ahead….
Geri Taylor, a participant in the aducanumab (Aduhelm) clinical trial, and her husband Jim share insights about taking part in the research. UPDATE: 3…
Biogen’s aducanumab — a human antibody-based drug that targets beta-amyloid plaques, which are found in the brains of people with Alzheimer’s — has gone…
With the right signals, non-differentiated human cells called stem cells have the potential to divide and multiply into all different types of cells. Due…
Scientists are diversifying their approaches to finding an effective treatment for Alzheimer’s as clinical trials targeting beta-amyloid plaques, one of the hallmarks of the…
In search of an animal model more comparable to the human brain, Alzheimer’s researchers are turning from mice to monkeys. Animal testing remains controversial,…
A new approach to genome sequencing newly identifies 13 rare gene variants potentially associated with Alzheimer’s. Dr. Rudy Tanzi, vice chair of neurology and…
As part of our LiveTalk series, Being Patient spoke with John Gastil and movement disorder specialist Dr. Zoltan Mari about the symptoms, diagnosis and…
People are always looking for an accessible, prescription-free aid for pain, insomnia, anxiety and other day-to-day irritations. In recent years, CBD has emerged as…
In 2013, Amylyx Pharmaceuticals co-founders Justin Klee and Josh Cohen, undergraduate students at Brown University at the time, hypothesized that targeting two dysfunctional pathways…
What if the reason we can’t seem to crack the code on how to prevent, treat, or even fully understand Alzheimer’s disease is that……
This weekend, Eli Lilly and Company presented detailed results of its phase 2 TRAILBLAZER-ALZ trial, showing that its investigational drug donanemab — monoclonal antibody…
(UPDATED Sat. March 13, 2021) In January, excitement rippled through the Alzheimer’s community with drugmaker Eli Lilly and Company’s announcement that their experimental drug…
Neuroscientist Kristen Willeumier, author of Biohack Your Brain, discusses the symptoms of stress-related brain fog and strategies to combat it. During these unprecedented times,…
The Alzheimer’s Drug, Oligomannate, approved in China and derived from seaweed, is now being studied in the U.S. in a Phase 3, multi-center clinical…